P/E společnosti Illumina
Jaká je hodnota metriky P/E společnosti Illumina?
Hodnota metriky P/E společnosti Illumina, Inc. je N/A
Jaká je definice metriky P/E?
P/E ratio je koeficient daný poměrem ceny akcie a příjmu společnosti na akcii za posledních 12 měsíců.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E společností v sektoru Miscellaneous sektor na LSE ve srovnání se společností Illumina
Čemu se věnuje společnost Illumina?
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.
Firmy s metrikou p/e podobnou společnosti Illumina
- Hodnota metriky P/E společnosti Enviro Technologie je N/A
- Hodnota metriky P/E společnosti Arcimoto je N/A
- Hodnota metriky P/E společnosti Tata Sponge Iron je N/A
- Hodnota metriky P/E společnosti Sathavahana Ispat je N/A
- Hodnota metriky P/E společnosti Crossword Cybersecurity Plc je N/A
- Hodnota metriky P/E společnosti Urban Exposure Plc je N/A
- Hodnota metriky P/E společnosti Illumina je N/A
- Hodnota metriky P/E společnosti Revolution Lighting Technologies je N/A
- Hodnota metriky P/E společnosti Vroom je N/A
- Hodnota metriky P/E společnosti Orphazyme A/S je N/A
- Hodnota metriky P/E společnosti Govind Rubber je N/A
- Hodnota metriky P/E společnosti Rdi Reit P.L.C je N/A
- Hodnota metriky P/E společnosti Acorn Income Fund je N/A